About Nakanishi, Inc. 
Nakanishi, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.04%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
20,647 Million
(Quarterly Results - Jun 2025)
Net Profit:
3,070 Million
Pharmaceuticals & Biotechnology
JPY 197,019 Million (Small Cap)
26.00
NA
0.00%
-0.23
5.30%
1.68






